- Telehealth Visits
Christopher Dvorak, MD
Medical Oncology • Pediatric Hematology-OncologyChief, Pediatric Allergy, Immunology and Bone Marrow Transplant Division- Telehealth Visits
Christopher Dvorak, MD
Medical Oncology • Pediatric Hematology-OncologyChief, Pediatric Allergy, Immunology and Bone Marrow Transplant Division- Telehealth Visits
On this page
About me
Dr. Christopher Dvorak is a specialist in stem cell transplantation for children with immunodeficiencies, blood disorders and cancer. He is chief of the UCSF Pediatric Allergy, Immunology and Bone Marrow Transplantation (BMT) Division and director of the Pediatric Cellular Therapy Laboratory.
In his research, Dvorak studies ways to lower the incidence of relapse in patients who have stem cell transplants for childhood leukemia. He also investigates how to minimize BMT complications and how to improve outcomes after stem cell transplants for severe combined immunodeficiencies (genetic disorders in which infants lack normal immune function), often called SCID.
Dvorak earned his medical degree at Vanderbilt University School of Medicine. He completed a residency in pediatrics as well as a fellowship in pediatric hematology, oncology and BMT at Stanford Medicine. Prior to joining UCSF in 2007, he was a clinical instructor for Stanford Medicine in the pediatric stem cell transplantation division
Dvorak is a national co-leader of the Primary Immune Deficiency Treatment Consortium, and he leads the Cancer Control and Supportive Care Committee for the Children's Oncology Group.
Education
Board Certification
- Pediatric Hematology-Oncology, American Board of Pediatrics
Fellowship
- Ped. Hema/Oncology, Lucile Salter Packard Childrens Hospital -Stanford
Residency
- Pediatrics, Stanford University Medical Center-GME
Internship
- Pediatrics, Stanford University Medical Center-GME
School
- MD, Vanderbilt University
Academic Title
- Clinical Professor
Care Keywords
Services
- Medical Oncology
- Pediatric Hematology-Oncology
- Blood and Marrow Transplant and Cellular Therapy
Provider Research Listing
Browse clinical trials and publications by this provider
Clinical trials
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell TransplantOpens in a new window
Recruiting
The cumulative incidence of Grade III-IV acute GVHD at Day 100 will be summarized by incidence curves. GVHD evaluations will be performed using standard criter...EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV InfectionOpens in a new window
Recruiting
Patients will be monitored for adverse events related to the infusion of EBV CTLs
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.